Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Aerts

Showing results (121-130 of 360) with videos related to

Pageof 36
Sort By:
Haematologica|June 4, 2008
Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapyMaaike de Fost, Carel J M van Noesel, Johannes M F G Aerts, et al.
Carbohydrate Research|April 12, 2016
Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher diseaseEugénie Laigre, Damien Hazelard, Josefina Casas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2003
alpha-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry diseaseGabor E Linthorst, Carla E M Hollak, Johanna C Korevaar, et al.
Blood Cells, Molecules & Diseases|August 30, 2005
Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher diseasePatrick B Deegan, Mary Teresa Moran, Ian McFarlane, et al.
Analytica Chimica Acta|May 22, 2007
Assessing the statistical validity of proteomics based biomarkersSuzanne Smit, Mariëlle J van Breemen, Huub C J Hoefsloot, et al.
FEBS Letters|November 3, 2007
TLR- and NOD2-dependent regulation of human phagocyte-specific chitotriosidaseMarco van Eijk, Saskia S Scheij, Cindy P A A van Roomen, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 1, 2005
Marked differences in tissue-specific expression of chitinases in mouse and manRolf G Boot, Anton P Bussink, Marri Verhoek, et al.
Kidney International|January 10, 2014
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry diseaseLiming Shu, Anuradha Vivekanandan-Giri, Subramaniam Pennathur, et al.
Journal of Inherited Metabolic Disease|May 17, 2014
Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapyL van Dussen, E J Hendriks, J E M Groener, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Design and synthesis of 2-acetamidomethyl derivatives of isofagomine as potential inhibitors of human lysosomal beta-hexosaminidasesRichard J B H N van den Berg, Wilma Donker-Koopman, Jacques H van Boom, et al.
Pageof 36

Showing results (121-130 of 360) with videos related to

Sort By:
Pageof 36
Haematologica|June 4, 2008
Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapyMaaike de Fost, Carel J M van Noesel, Johannes M F G Aerts, et al.
Carbohydrate Research|April 12, 2016
Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher diseaseEugénie Laigre, Damien Hazelard, Josefina Casas, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2003
alpha-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry diseaseGabor E Linthorst, Carla E M Hollak, Johanna C Korevaar, et al.
Blood Cells, Molecules & Diseases|August 30, 2005
Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher diseasePatrick B Deegan, Mary Teresa Moran, Ian McFarlane, et al.
Analytica Chimica Acta|May 22, 2007
Assessing the statistical validity of proteomics based biomarkersSuzanne Smit, Mariëlle J van Breemen, Huub C J Hoefsloot, et al.
FEBS Letters|November 3, 2007
TLR- and NOD2-dependent regulation of human phagocyte-specific chitotriosidaseMarco van Eijk, Saskia S Scheij, Cindy P A A van Roomen, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 1, 2005
Marked differences in tissue-specific expression of chitinases in mouse and manRolf G Boot, Anton P Bussink, Marri Verhoek, et al.
Kidney International|January 10, 2014
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry diseaseLiming Shu, Anuradha Vivekanandan-Giri, Subramaniam Pennathur, et al.
Journal of Inherited Metabolic Disease|May 17, 2014
Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapyL van Dussen, E J Hendriks, J E M Groener, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Design and synthesis of 2-acetamidomethyl derivatives of isofagomine as potential inhibitors of human lysosomal beta-hexosaminidasesRichard J B H N van den Berg, Wilma Donker-Koopman, Jacques H van Boom, et al.
Pageof 36